Article: What's in the pipeline for dry eye and ocular allergy?

Pharmaceutical development

New therapeutics focus on causes, prevention

Dry eye and ocular allergy are bothersome to patients and present challenges to clinicians who, until recently, had limited treatment options that were typically directed at alleviating symptoms. Now, however, new therapeutic agents in the pipeline could change all of that. Researchers have begun developing therapies for dry eye that are directed at treating lhe underlying causes rather than symptoms. In addition, new therapies tor ocular allergy are focused on preventing the allergic reaction. This article discusses the newest agents being developed for dry eye and ocular allergy and reviews existing treatments ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!